Trial record 1 of 12 for:    Immunovative
Previous Study | Return to List | Next Study

AlloStim® In-Situ Vaccine in Pre-Treated Metastatic Colorectal Cancer

This study is not yet open for participant recruitment. (see Contacts and Locations)
Verified August 2016 by Immunovative Therapies, Ltd.
Sponsor:
Information provided by (Responsible Party):
Immunovative Therapies, Ltd.
ClinicalTrials.gov Identifier:
NCT01741038
First received: November 29, 2012
Last updated: August 7, 2016
Last verified: August 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is not yet open for participant recruitment.
  Estimated Study Completion Date: October 2020
  Estimated Primary Completion Date: December 2019 (Final data collection date for primary outcome measure)